This project presents one application direction of the IARIP research architecture. The presented model is currently in the research and pilot validation phase. The timelines below outline the expected validation and development steps of the IARIP research architecture across different application domains. Following research validation, IARIP aims to initiate real-world projects together with industry and market partners based on the successfully validated models.

A non-invasive measurement and digital monitoring infrastructure for early detection of health trends

Program Objective and Strategic Role

The National Biosensor and Digital Health Monitoring Program aims to establish a nationwide, non-invasive health monitoring infrastructure that uses biosensor-based measurements and digital data processing to enable the continuous observation of health trends, physiological load, and early deviations.

The program is neither diagnostic nor therapeutic. Its role is to:

• – make unfavorable health trajectories detectable at an early stage,
• – support prevention and lifestyle-based interventions,
• – provide a data-driven foundation for institutional and national-level decision-making.

Core Program Logic

The system treats health as a continuously evolving state, placing emphasis on longitudinal trends rather than single-point measurements.

Three integrated levels:

1. Individual Level – Personal State Monitoring

• – home-based and wearable biosensor devices
• – regular, non-invasive measurements
• – feedback relative to individual baseline states

2. Institutional Level – Aggregated Observation

• – analysis of anonymized, aggregated datasets
• – identification of regional and demographic health trends
• – support for targeted prevention initiatives

3. National Level – Strategic Planning

• – data-informed health policy development
• – long-term reduction of healthcare system load
• – stabilization of national digital health infrastructure

Technological and Operational Components

Biosensor Measurement Layer:

• – proxy measurements related to stress, inflammation, and metabolic load
• – validated, non-invasive sensor technologies
• – collection of longitudinal time-series data

Digital Data Processing:

• – noise filtering and normalization
• – trend and pattern analysis
• – generation of comparable population-level indicators

Data Security and Ethics:

• – voluntary participation based on informed consent
• – full anonymization and aggregation
• – transparent and accountable data governance frameworks

Program Phases (2–6 Years)

Phase 1 – Pilot and Technology Validation (Years 1–2)

• – limited regional or institutional pilot deployment
• – testing of measurement and data-processing models
• – collection of public and institutional feedback

Phase 2 – Regional Expansion (Years 3–4)

• – inclusion of multiple regions
• – creation of comparable health-trend databases
• – support for region-specific prevention programs

Phase 3 – Nationwide Operation (Years 5–6)

• – stable, nationwide health monitoring system
• – regular national health trend reports
• – continuous strategic decision support

Institutional Stakeholders

• – public health and healthcare institutions
• – digital government and smart city programs
• – insurance and prevention-focused organizations
• – universities and research institutes
• – sensor technology and digital health partners

Expected Societal and Economic Impact

• – early detection of adverse health trends → fewer chronic conditions
• – reduced long-term healthcare burden
• – more efficient and targeted prevention strategies
• – increased digital health awareness
• – sustained healthcare cost savings

Alignment with the AVA Development Framework

Within this program, AVA operates as an analytical and coordinating intelligence layer, supporting:

• – structuring and interpretation of biosensor-derived data,
• – identification of trends and anomalies,
• – guidance for prevention strategies and long-term planning.

The National Biosensor and Digital Health Monitoring Program thus completes and stabilizes the national Bio–Nano and health-technology program portfolio, providing a solid foundation for future large-scale health ecosystem initiatives.